Fundraising Fox

Antios Therapeutics

Mendham, US · Founded 2018 · Delaware corporation · 3 known investors

Biotechin /antios@AntiosTx

Founders & leadership

AD
Abel De La RosaDirector
IR
Iyona RajkomarDirector
DM
Douglas MayersExecutive Officer
BR
Benjamin RovinskiDirector
PH
Patrick HigginsDirector
TA
Tamra AdamsExecutive Officer
SM
Scott MorensteinDirector
DC
David CannerDirector
GM
Gregory MayesExecutive Officer, Director

Investors · 3

Aisling CapitalNew York
Avego BioScience CapitalAlpharetta
Pontifax Venture CapitalHerzeliya · $6.3M – $128M

Reported raises · per SEC filings

Form D private placements
▶$75MraisedNov 2021 · 35 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin RovinskiDirector
  • Scott MorensteinDirector
  • Tamra AdamsExecutive Officer
  • Craig GordonDirector
  • Gregory MayesExecutive Officer, Director
  • Abel De La RosaDirector
  • Douglas MayersExecutive Officer
  • Patrick HigginsDirector
  • Iyona RajkomarDirector
Offering amount
$86M
Amount sold
$75M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32MraisedApr 2021 · 29 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Abel De La RosaDirector
  • Iyona RajkomarDirector
  • Douglas MayersExecutive Officer
  • Benjamin RovinskiDirector
  • Patrick HigginsDirector
  • Tamra AdamsExecutive Officer
  • Scott MorensteinDirector
  • David CannerDirector
  • Gregory MayesExecutive Officer, Director
Offering amount
$100M
Amount sold
$32M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedAug 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Idean MarvastyExecutive Officer
  • Douglas MayersExecutive Officer
  • Abel De La RosaExecutive Officer, Director
  • Nicole VitulloDirector
  • Henry Lin ChenDirector
  • Benjamin RovinskiDirector
  • Scott MorensteinDirector
Offering amount
$5M
Amount sold
$4.4M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedDec 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin RovinskiDirector
  • Abel De La RosaExecutive Officer, Director
  • Nicole VitulioDirector
  • Henry Lin ChenDirector
  • Douglas MayersExecutive Officer
  • Scott MorensteinDirector
  • Idean MarvastyExecutive Officer
Offering amount
$25M
Amount sold
$15M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.